| Identification | Back Directory | [Name]
Seladelpar lysine | [CAS]
928821-40-3 | [Synonyms]
MBX-8025 Lysine
Seladelpar lysine
MBX-8025 lysine dihydrate
MBX 8025 Lysine MBX8025 Lysine | [Molecular Formula]
C27H37F3N2O7S | [MOL File]
928821-40-3.mol | [Molecular Weight]
590.66 |
| Hazard Information | Back Directory | [Uses]
Seladelpar (MBX-8025) Lysine dihydrate is the Lysine dihydrate salt form of Seladelpar (HY-19522). Seladelpar Lysine dihydrate is an orally active agonist for potent PPAR-δ, with EC50 of 2 nM. Seladelpar Lysine dihydrate shows more than 750-fold and 2500-fold selectivity over the PPARα and PPARγ receptors, respectively. Seladelpar Lysine dihydrate can be used for the study of primary biliary cholangitis. Seladelpar Lysine dihydrate normalizes hyperglycemia, hyperinsulinemia, glucose, serum lipids and cholesterol levels, ameliorates the nonalcoholic steatohepatitis in mouse model[1][2]. | [IC 50]
PPARδ: 2 nM (EC50) | [References]
[1] Bays HE, et al. MBX-8025, a novel peroxisome proliferator receptor-delta agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin. J Clin Endocrinol Metab. 2011 Sep;96(9):2889-97. DOI:10.1210/jc.2011-1061
[2] Haczeyni F, et al. The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice. Hepatol Commun. 2017 Jul 31;1(7):663-674. DOI:10.1002/hep4.1072 |
|
|